首页> 外文期刊>世界急诊医学杂志(英文) >Prognosis of patients with shock receiving vasopressors
【24h】

Prognosis of patients with shock receiving vasopressors

机译:休克接受血管加压药的患者的预后

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Consensus guidelines suggested that both dopamine and norepinephrine may be used, but specific doses are not recommended. The aim of this study is to determine the predictive role of vasopressors in patients with shock in intensive care unit.METHODS: One hundred and twenty-two patients, who had received vasopressors for 1 hour or more in intensive care unit (ICU) between October 2008 and October 2011, were included.There were 85 men and 37 women, with a median age of 65 years (55-73 years). Their clinical data were retrospectively collected and analyzed.RESULTS: The median simplified acute physiological score 3 (SAPS 3) was 50 (42-55). Multivariate analysis showed that septic shock (P=0.018, relative risk: 4.094; 95% confi dential interval: 1.274-13.156), SAPS 3 score at ICU admission (P=0.028, relative risk: 1.079; 95% confidential interval: 1.008-1.155), and norepinephrine administration (P<0.001, relative risk: 9.353; 95% confidential interval: 2.667-32.807) were independent predictors of ICU death. Receiver operating characteristic curve analysis demonstrated that administration of norepinephrine ≥0.7 μg/kg per minute resulted in a sensitivity of 75.9% and a specifi city of 90.3% for the likelihood of ICU death. In patients who received norepinephrine ≥0.7 μg/kg per minute there was more ICU death (71.4% vs. 44.8%) and in-hospital death (76.2% vs. 48.3%) than in those who received norepinephrine <0.7 μg/kg per minute. These patients had also a decreased 510-day survival rate compared with those who received norepinephrine <0.7 μg/kg per minute (19.2% vs. 64.2%).CONCLUSION: Septic shock, SAPS 3 score at ICU admission, and norepinephrine administration were independent predictors of ICU death for patients with shock. Patients who received norepinephrine ≥0.7 μg/kg per minute had an increased ICU mortality, an increased in-hospital mortality, and a decreased 510-day survival rate.
机译:背景:共识性指南建议多巴胺和去甲肾上腺素均可使用,但不建议使用特定剂量。这项研究的目的是确定升压药在重症监护病房休克患者中的预测作用。方法:102名在10月至10月间在重症监护病房(ICU)接受过1小时或更长时间血管加压药的患者。包括2008年和2011年10月,男性85位,女性37位,中位年龄为65岁(55-73岁)。结果:回顾性平均急性生理评分3(SAPS 3)为50(42-55)。多因素分析显示败血性休克(P = 0.018,相对危险度:4.094; 95%机密区间:1.274-13.156),ICU入院时SAPS 3评分(P = 0.028,相对危险度:1.079; 95%机密区间:1.008- 1.155)和去甲肾上腺素的使用(P <0.001,相对危险度:9.353; 95%可信区间:2.667-32.807)是ICU死亡的独立预测因子。受试者工作特征曲线分析表明,每分钟每分钟给予≥0.7μg/ kg的去甲肾上腺素,ICU死亡的敏感性为75.9%,特定城市为90.3%。每分钟接受去甲肾上腺素≥0.7μg/ kg的患者比接受去甲肾上腺素<0.7μg/ kg /分钟的患者的ICU死亡(71.4%vs. 44.8%)和院内死亡(76.2%vs. 48.3%)多分钟。与接受去甲肾上腺素<0.7μg/ kg /分钟的患者相比,这些患者的510天生存率也降低了(19.2%对64.2%)。结论:败血性休克,ICU入院时SAPS 3评分和去甲肾上腺素给药是独立的休克患者ICU死亡的预测指标。每分钟接受去甲肾上腺素≥0.7μg/ kg的患者,ICU死亡率增加,医院内死亡率增加,510天生存率降低。

著录项

  • 来源
    《世界急诊医学杂志(英文)》 |2013年第001期|59-62|共4页
  • 作者单位

    Department of Intensive Care Unit, Cancer Hospital (Institute), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China;

    Department of Intensive Care Unit, Cancer Hospital (Institute), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China;

    Department of Intensive Care Unit, Cancer Hospital (Institute), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China;

    Department of Intensive Care Unit, Cancer Hospital (Institute), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China;

    Department of Intensive Care Unit, Cancer Hospital (Institute), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China;

    Department of Intensive Care Unit, Cancer Hospital (Institute), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China;

    Department of Intensive Care Unit, Cancer Hospital (Institute), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China;

    Department of Intensive Care Unit, Cancer Hospital (Institute), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China;

    Department of Intensive Care Unit, Cancer Hospital (Institute), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China;

    Department of Intensive Care Unit, Cancer Hospital (Institute), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 04:13:14
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号